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The nephrotic syndrome is characterized by pro-
fuse albuminuria, hypoalbuminemia, generalized
edema, and usually hyperlipidemia [1]. The syn-
drome occurs world wide and may occur at any age,
but it has a predeliction for the early years of life [2,
3]. Many etiologic factors have been incriminated,
and the renal pathology is extremely variable, but in
most cases seen in childhood, in temperate cli-
mates, no specific cause can be identified, and renal
histology by light microscopy is unremarkable.
Such cases are referred to as "idiopathic" or "mini-
mal change" nephrotic syndrome and are represen-
tative of the vast majority of patients who constitute
the basis for the considerable world literature on the
nephrotic syndrome in childhood [4].
In developing countries in the tropics, the pattern
and prevalence of childhood diseases in general and
of renal disease in particular remains poorly de-
fined. Clinical recognition of renal disease is ren-
dered difficult because endemic diseases such as,
for example, nutritional edema and urinary schis-
tosomiasis may simulate, distort, or obscure renal
pathology, and conditions of practice usually pre-
clude the use of sophisticated radiologic, biochemi-
cal, pathologic, and immunologic investigations re-
quired to identify and characterize renal disorders.
The advent of medical schools in tropical Africa
in recent times, with their associated teaching hos-
pitals, facilitated investigation of renal disease and
disclosed an unusually high prevalence of the ne-
phrotic syndrome in childhood in areas where the
condition previously was recognized seldom and was
Received for publication November 10, 1978
0085-2538/79/0016-0064 $02.20
© 1979 by the International Society of Nephrology
64
presumed to be rare [5-7]. In contrast to European
and American experience, that an etiologic agent is
seldom identified in the nephrotic syndrome, expe-
rience in tropical Africa has revealed a very definite
etiologic association between the nephrotic syn-
drome and infection with Plasmodium malariae [5-
8]. While acknowledging the pitfalls of extrapolat-
ing from experience in specialized institutions to
communities at large, we find it difficult to avoid the
conclusion, based on all evidence currently avail-
able, that the nephrotic syndrome associated with
quartan malaria is a prevalent and serious disorder
in tropical countries, and in a global context, quar-
tan malaria probably represents the single most im-
portant etiologic factor identified to date in the
nephrotic syndrome in childhood.
This account is an attempt to synthesize available
information about the clinical features and clini-
copathologic correlations in the quartan malarial
nephrotic syndrome in children and draws largely
on experience acquired over the past 20 years by us
in the Nephrosis Clinic of the Department of Pae-
diatrics of the University of Ibadan, Nigeria.
Historical note. Reference to an association be-
tween P. malariae and renal disease can be found in
the tropical medicine literature dating back to the
last century [9].
Watson in 1905, reviewing the clinical features of
P. malariae infections, remarked on the presence of
edema and albuminuria in several of his patients
[10], and Clarke in 1912 felt strongly enough about
the association to write, "I believe that the occur-
rence of edema in the tropics, of such a nature as to
make one think of parenchymatous nephritis is a
reason for making a search for quartan malaria
parasites imperative" [11]. In 1917, MeFie and In-
gram reported nine cases of the nephrotic syndrome
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in children under 10 years of age in the Gold Coast,
all of whom had P. malariae in the peripheral blood
[12]. In 1930, Giglioli made a major contribution to
the subject when he reported on his survey of renal
disease and its relationship to P. malariae carried
out in British Guiana between 1923 and 1929 [13].
He noted a close relationship between P. malariae
infection, albuminuria, and the nephrotic syndrome
and postulated a causal association. Subsequently,
reports from Sumatra [14], Suriname [15], Kenya
[16], Solomon Islands and New Guinea [17], and In-
dia [18] all supported Giglioli's observations. In
1948 Maegraith [19], after critically reviewing the
literature, accepted the association between P. ma-
lariae and the nephrotic syndrome, but his view
gained little support, and in general the suggestion
of a relationship between quartan malaria and the
nephrotic syndrome was ignored or treated with in-
credulity in publications on medicine in the tropics
[20]. As recently as 1958, not only was the relation-
ship generally regarded as unproven, but it was also
popularly believed that the nephrotic syndrome is a
rare entity in pediatric practice in the tropics [21].
In 1963 Gilles and Hendrickse [6] published their
findings of a comparative study of P. malariae prev-
alence in 113 nephrotic children, 920 ill non-
nephrotic children, and 340 "healthy" village chil-
dren in Western Nigeria. Their results showed a
highly significant selective increase in P. malariae
parasitemia in the nephrotic children (P < 0.001
for both sets of controls), confirming beyond any
reasonable doubt a relationship between P. ma-
lariae and the nephrotic syndrome. Comparison of
the age distribution of the nephrotic patients with
the age-specific prevalence of P. malariae in the
community provided additional epidemiologic evi-
dence of a specific relationship [6].
These findings were interpreted as evidence of a
causal relationship between P. malariae infection
and the nephrotic syndrome. The alternative that
children with the nephrotic syndrome have an in-
creased susceptibility toP. malariae infection could
not be completely disproved, but seemed unlikely
in view of Giglioli's observations in British Guiana,
that following malaria eradication there, the ne-
phrotic syndrome, which had previously been com-
mon, had become a rare condition [22, 23]. Sub-
sequent clinical studies have put the causal relation-
ship between P. malariae and the nephrotic
syndrome beyond any reasonable doubt.
(I) P. malariae is significantly more prevalent
among younger children than it is among older chil-
dren presenting with the nephrotic syndrome, and is
more frequently associated with the earlier than it is
the later stages of the disease [24]. The reverse
would be anticipated if the nephrotic syndrome pre-
disposed to infection with P. malariae.
(2) P. malariae antigen has been demonstrated in
renal lesions in about one third of patients with the
nephrotic syndrome [24-27].
(3) In a prospective study of nephrotic and non-
nephrotic children in a hyperendemic malarious
area, the subjects were initially cleared of malarial
parasitemia and then monitored without any ma-
laria chemoprophylaxis for evidence of reinfection.
There was no discernible difference in susceptibility
to malaria in the two groups of children [28].
Direct evidence of the etiologic role of quartan
malaria in the nephrotic syndrome is provided by
observations made in circumstances which exclude
any possibility than quartan malarial infection fol-
lowed rather than caused the nephrotic syndrome.
Keital et al [29] described a case of congenital quar-
tan malaria which presented with the nephrotic syn-
drome at 21 months of age. The drug-addicted
mother had acquired her infection by syringe in-
oculation in a nonmalarious area. Complete remis-
sion of the nephrotic syndrome occurred following
antimalarial treatment. Boyd [30], observing the
long-term effects of mosquito-transmitted and blood
inoculated quartan malaria in 38 adults, noted pro-
teinuria in all subjects, which was gross in 14, and
associated with edema in 6. Recent experimental
work on Aotus monkeys has confirmed that infec-
tion with quartan malaria to which these animals are
susceptible causes the nephrotic syndrome [31,
32].
The satisfactory response to antimalarial treat-
ment recorded by Keital et al [29], in their child
with congenital malaria, is in keeping with claims in
earlier publications [17, 30, 33] that antimalarial
treatment is effective in inducing remission of the
nephrotic syndrome of quartan malaria. The thera-
peutic value of antimalarials in this condition has
not been substantiated in more recent reports [6, 7].
The earliest studies on the pathology of quartan
malarial nephrosis (QMN) included a careful search
for P. malariae or malarial pigment in renal tissues.
These studies failed to demonstrate P. malariae or
malarial pigment in the renal lesions, and it seemed
highly improbable, therefore, that renal changes re-
flected direct injury by the P. malariae parasite [6,
7, 34, 35]. Hendrickse and Gilles [7] in 1963 sug-
gested that a possible explanation for the renal pa-
thology was that in some individuals infection with
P. malariae provokes an abnormal immunologic re-
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sponse in which antigen-antibody complexes dam-
age the glomerular basement membrane. The le-
sion, once initiated, tends to be progressive and un-
influenced by antimalarial treatment. If this
hypothesis was correct, then, with appropriate
techniques, antigen-antibody complexes should be
demonstrated in the kidneys of these patients.
This proved to be the case when Dixon sub-
sequently examined some renal biopsy specimens
from their patients by immunofluorescence micros-
copy. He found coarse, granular, immunofluores-
cent deposits containing IgG and C3 in all the speci-
mens examined [36]. This was the first demonstra-
tion of immune complexes in the kidneys of patients
with the nephrotic syndrome of quartan malaria
(Fig. 1). It provided support for the hypothesis of an
immunologically mediated disorder and proved a
potent stimulus to subsequent immunologic investi-
gation of the condition.
Renal pathology
Very early in the study of the nephrotic syndrome
in Africa, it became apparent that the minimal
change" histology that characterizes the condition
in childhood elsewhere was a rare finding. Most
renal biopsy specimens showed definite and fairly
gross pathologic features. The essential lesion
noted was thickening of the capillary walls in the
glomerular tuft leading to eventual glomerular scle-
rosis. Associated features described included vari-
able endocapillary cell proliferation, capsular adhe-
sions, and features of pyelonephritis [6—8, 35]. At-
tempts to fit the histologic changes observed into
classifications of renal pathology based on Euro-
pean and American experience [4, 37, 38] proved
difficult, and incomplete clinical and biochemical
data in many cases confounded attempts at accurate
clinicopathologic correlation [35]. It now must be
accepted that some of the earlier descriptions of his-
topathologic features of the nephrotic syndrome as-
cribed to quartan malaria included material from pa-
tients with variants of poststreptococcal glomerular
nephritis and other etiologic entities.
Edington and Mainwaring in 1966 summarized
the state of knowledge of quartan malarial nephrotic
syndrome as follows: the lesions that P. malariae
may cause in the kidney either directly or indirectly
must still be elucidated, but it is considered that
these lesions will most probably be those of a local-
ized focal glomerulitis with tubular changes, de-
scribed in this discussion as severe lipoid nephrosis.
Their differentiation from the lesions found in post-
Fig. 1. First demonstration of immune complexes in the quartan malarial nephrotic syndrome (QMN), showing
positive fluorescence for IgG.
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Fig. 2. Typical histologic appearance in QMN. Note plexiform thickening of capillary walls, little mes-
angial expansion and lack of cellular proliferation. (PAS; x290)
streptococcal nephritis will always be difficult and
require careful clinicopathologic studies in indi-
vidual patients" [35].
Subsequent collaborative clinicopathologic-im-
munologic studies [24] have done much to clarify
the pathology of the quartan malarial nephrotic syn-
drome, which can be summarized as follows: The
essential lesion is thickening of the glomerular cap-
illary walls, which in early cases affects only a few
glomeruli in a segmental manner. The thickening in-
volves the subendothelial aspects of the basement
membrane and gives rise to a double contour or
plexiform arrangement of PAS positive, argyrophil-
ic fibrils (Figs. 2 and 3). As the disease progresses,
Fig. 3. Part of glomerulus, showing capillary wall thickening with plexiform arrangement of agyrophilic
fibrils in subendothelial region. Note variability of extent of capillary lesion. (PASM; x680)
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Fig. 4. End-stage QMN. Note complete hyalinization of glomeruli, tubular atrophy, and interstitial round
cell infiltration. (PAS; x 34)
more capillaries become affected, and the lesions
extend to cause progressive narrowing and even-
tually complete obliteration of capillary lumens.
The mesangium shares in this sclerosing process,
which is initially segmental but ultimately becomes
diffuse, leading to total glomerular sclerosis (Fig. 4).
Cellular proliferation is typically absent although
occasional foci of hypercellularity may be seen
sometimes. The capsular space is usually present,
but in a few cases small fibroepithelial crescents,
locally adherent to the glomerular tuft, may occur.
Hyaline droplets in the proximal tubules are com-
mon. The extent of tubular atrophy and interstitial
round cell infiltration reflects the degree of glomeru-
lar damage to which they are apparently secondary.
Biopsy specimens designated QMN were graded
for severity by the pathologists in a collaborative
study of children presenting in Ibadan, Nigeria, as
follows [24]: Grade 1. Up to 30% of glomeruli
showed definite evidence of glomerular lesions,
consisting mainly of localized capillary wall thick-
ening and segmental sclerosis. Grade II. Thirty to
seventy-five percent of glomeruli were affected,
with segmental or diffuse capillary-wall thickening
and sclerosis, often producing a honeycomb" ap-
pearance. Occasional adhesions and areas of tubu-
lar atrophy were also seen. Grade III. More than
75% of glomeruli were affected. Extensive mesangi-
al sclerosis and plexiform thickening of the capillary
walls were diffuse, resulting in narrowed or even
completely obliterated lumens. Total glomerular
sclerosis, tubular atrophy, and interstitial infil-
tration were also prominent. This grading has some
predictive value in relation to response to therapy.
All cases who have responded to prednisolone or
immunosuppressive drugs like cyclophosphamide
and azathioprine have fallen into grade I, and all
cases in grades II and III have been nonresponsive
to any form of treatment. It must be acknowledged,
however, that the majority of patients in grade I
show no essential differences in their clinical behav-
ior and response to treatment from those graded II
and III. This finding indicates the need to refine the
criteria for grading the pathology of QMN.
The ultramicroscopic findings in QMN are based
on more limited study than light microscopic find-
ings are. The description that follows reflects expe-
rience of 22 specimens from Ibadan that were exam-
ined in Birmingham, by Glasgow and White [24].
These findings have some support from more limit-
ed observations elsewhere [39].
The essential abnormality is thickening of the
capillary basement membrane. This is variable in
amount and consists of an increase in the sub-
endothelial basement membrane-like material of
varying density in the subendothelial zone, as well
as occasional aggregations of electron-dense and
cytoplasmic material within the basement mem-
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Fig. 5. Electron microscopy of QMN. The basement membrane
is irregularly thickened and contains lacunae, many of which
contain electron-dense material. (x 23,100)
brane itself. Small lacunae scattered throughout the
basement membrane, often containing an island of
material similar in density to the basement mem-
brane, were present in every specimen designated
QMN on light microscopy in the Ibadan study
(Fig. 5). The characteristic subepithelial deposits
("humps") classically described in poststreptococ-
cal mesangial proliferative nephritis and which were
reported in an earlier description of electron micro-
scopic appearance in the nephrotic syndrome of
African children [40], were not seen in any of these
QMN biopsy specimens.
Immunofluorescent microscopy. With occasion-
al exceptions only, immunoglobulin deposits have
been regularly detected in renal biopsy specimens
of QMN [24-27, 40, 41]. Three patterns of fluores-
cence have been observed. (1) Coarse, medium-
sized, granular deposits distributed along the capil-
lary walls is the most common finding, (2) a diffuse
pattern of very fine deposits homogeneously distrib-
uted along the vessel walls occurs in a minority of
patients, (3) a mixture of granular and diffuse depos-
its in different proportions is observed often but oc-
curs less frequently than does the coarse granular
pattern. IgG and 1gM usually are detected together,
but either may occur alone in the granular and
mixed patterns, usually in association with the C3
component of complement, but fluorescence of C3
is always granular and tends to be less widely dis-
tributed than is immunoglobulin fluorescence. Pa-
tients with diffuse fluorescence are rarely com-
plement-positive and tend to have IgG fluorescence
only. Detection of IgA is exceptional. In about one
third of subjects P. malariae antigen is detected. A
more detailed description of these immunologic
findings is given elsewhere.
There appears to be no specific relationship be-
tween histologic grading on light microscopy and
pattern of immunofluorescence observed. All three
patterns of immunofluorescence have been seen in
association with the three histologic grades [24].
There appears to be a relationship between the pat-
tern of immunoglobulin fluorescence and response
to treatment. Most responders have granular fluo-
rescence, and the remainder fall into the mixed
pattern. No patient showing diffuse immunofluo-
rescence has shown a satisfactory response to treat-
ment. Irrespective of the pattern of immunofluo-
rescence, no patient graded II or III on histology
has shown a response to treatment [24]. Immuno-
fluorescent deposits disappear or become much less
evident in repeat renal biopsy specimens of patients
who respond to treatment. Immunofluorescence
persists, may intensify, or may change its character
from granular to diffuse in repeat biopsy specimens
on nonresponders to treatment [42].
Table 1 correlates immunofluorescent findings
with histology, selectivity of proteinuria, and re-
sponse to treatment in a series of 41 children with
the nephrotic syndrome studied in Ibadan and Bir-
mingham [24]. Whereas the majority of patients
with non-QMN histology respond to treatment, on-
ly a small minority of QMN cases, all in grade I and
showing a granular or mixed pattern of fluores-
cence, respond to treatment.
Clinicalfindings
Mode of presentation. Patients almost invariably
present with generalized edema. The onset may be
insidious starting initially as periorbital swelling on
waking, which disperses during the day, later be-
coming persistent and progressive over a period of
months. Alternatively, edema may be very rapid in
onset and reach gross proportions within a week.
The majority of patients have been edematous for 2
to 4 weeks at the time of presentation. Duration and
severity of edema show no specific correlation with
the severity of renal pathology.
Most patients complain of fever in the early
stages of their illness, and this may occasionally be
of the characteristic quartan type with spikes every
72 hours (Fig. 6). As the disease progresses, fever
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Table!. Correlation of immunofluorescent findings with histology, selectivity of proteinuria, and response to treatments
Renal morphology: Selectivity of proteinuria
QMN I QMN II QMN III MC and others
___________ _________ ___________ — ________________ Total good
High Mod. Poor High Mod. Poor High Mod. Poor High Mod. Poor responses
Immunofluorescent pattern
Granular OOX OOX OXX X XX X X X — 000 — 0 7/19
Mixed 0 — OXXXX — X XX — — XXXX 0 0 — 3/15
Diffuse — XX XX X — X — — X — — — 0/7
Total good responses 2/4 1/5
5/19
2/10 0/2 0/3
0/9
0/4 0/1 0/1
0/7
0/5 3/4 1/1
5/6
1/I
10/41
This figure is reprinted with the permission of Lancet [24].
hQ denotes good response; 0, fair response; X, poor response. MC is minimal change nephropathy; QMN is quartan malarial nephro-
sis.
diminishes. There are no other characteristic com-
plaints. In particular, it must be stressed that hema-
tuna, dysuria, and oliguria are admitted rarely,
even on direct questioning, although 24-hour urine
collection usually shows a significant reduction in
output.
Age and sex. The sexes appear to be equally af-
fected. The disease is rare during the first 2 years of
life, but thereafter increases in incidence to a peak
at about 5 years, after which prevalence gradually
declines but does not disappear, cases occurring in
adolescence and adult life. The age incidence con-
trasts with experience in Europe and America
where peak prevalence of the nephrotic syndrome
is between 2 and 3 years of age, after which it falls
sharply (Fig. 7).
Nutritional condition and social status. The vast
majority of patients are poor, badly nourished, illit-
erate peasants. This, in the main, reflects the eco-
nomic and social background against which this dis-
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ease occurs, but it is our distinct impression that
within the prevailing local nutritional spectrum, it is
the least well nourished who most frequently ac-
quire the disease.
Investigations of the correlations between malnu-
trition and malarial infection in areas where both P.
falciparum and P. malariae occur have shown that
whereas the prevalence of P. falciparu,n infection is
largely uninfluenced by nutritional status and the
disease may indeed be more severe in well-nour-
ished than poorly nourished subjects [431, P. ma-
lariae infections tend to be more frequent among
malnourished than they are among well-nourished
children [44].
Main physical findings. Edema is obvious in all
cases and is usually associated with ascites. In addi-
tion, some patients may have pleural effusions. The
detection of ascites is clinically important, as it dif-
ferentiates the nephrotic syndrome from Kwashior-
kor, in which ascites is a rare clinical finding. A
large, persistent, submental collection of edema is
another finding which is characteristic of the ne-
phrotic syndrome. The liver and the spleen are both
enlarged in about 50% of patients, and in a further
25% either the liver or the spleen may be enlarged.
The degree of enlargement of these organs is usual-
ly moderate and frequently masked by ascites, but
hepatosplenomegaly is sometimes gross and obvi-
ous. Most patients show some degree of anemia.
Associated findings and complications which are
not infrequently observed include respiratory infec-
tions, primary tuberculosis, severe anemia, gross
malnutrition, and specific childhood infections,
such as measles, whooping cough, and so forth.
The blood pressure is usually normal in the early
stages of this disease, but moderate hypertension
(BP> 120/80 mm Hg) does occasionally occur. The
detection of significant hypertension in a patient
Fig. 6. Temperature chart of a patient showing typical P. Ma-
lariae pattern of 72 hourly peaks.
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with a short history of illness should cause the phy-
sician to query the accuracy of the history or to re-
vise the diagnosis of quartan malarial nephrotic syn-
drorne. In the later stages of the disease, many pa-
tients develop hypertension. Administration of
prednisolone tends to precipitate or exacerbate hy-
pertension. It is exceptional to find evidence of re-
nal failure in the absence of hypertension.
Spontaneous remission in established cases of
quartan malarial nephrotic syndrome is very rare,
but significant reduction in edema and proteinuria
may occur following antimalarial chemotherapy and
other measures (see below).
Urinalysis. Proteinuria is heavy and persistent.
Spun urinary deposit typically shows a few leuko-
cytes, some granular and hyaline casts, and only oc-
casional red cells. Macroscopic hematuria does not
occur, and significant microscopic hematuria is un-
usual. The atypical patient who shows significant
hematuria tends to progress rapidly toward renal in-
sufficiency.
Differential protein clearance studies show that,
in contrast to experience with the idiopathic (mini-
mal change) nephrotic syndrome, the majority of
these patients have poorly selective proteinuria [24,
42, 45, 46]. Highly selective proteinuria occurs in
20% or less of patients, among whom are to be
found most of the small minority with this disease
who are responsive to prednisolone [24, 42, 45, 46].
Biochemicalfindings
The salient biochemical findings in the quartan
malarial nephrotic syndrome do not show any es-
sential differences from those classically described,
but they tend to be modified by environmental fac-
tors. Thus, plasma albumin concentrations tend to
be very low, and values well below 1.0 gIlOO ml are
the rule rather than they are the exception. Serum
globulin concentrations are higher than they are in
Europe but show little difference from those record-
ed in normal children in the same environment, ex-
cept for the elevation of the a2 fraction. Cholesterol
concentrations reflect the low dietary lipid intake
and tend to be much lower than are those observed
in European children with the nephrotic syndrome,
but they are significantly elevated by local stan-
dards. Blood urea concentrations are well within
the normal range in the early stages of the disease
[6, 7]. Serum complement (C3) is usually within the
normal range but occasionally may be depressed in
patients with recent onset of disease [46].
Immunoelectrophoretic studies of the com-
plement component C3 (/3-1-C) provide evidence to
support the concept of an immunologically mediat-
ed disease. C3 has been detected in the first peak of
"G-200 Sephadex" gel filtration of the serum of
some patients, as well as in the middle peak as nor-
mal, showing that it is incorporated into a macro-
molecular form, as would be expected if it were
bound to antigen excess soluble antigen-antibody
complexes [46].
Management, course, and prognosis
Management of these patients presents many
problems which are magnified under conditions of
practice in the tropics. Apart from short admissions
for special investigation or to treat serious compli-
cations, most patients have been managed as out-
patients. That control of edema is regarded as
"cure" by many leads to a high default rate with all
its attendant problems [7].
Most patients improve and lose edema in re-
sponse to initial management on a high-protein,
low-sodium diet, combined with the use of diuretics
and treatment of complications such as intercurrent
infections and anemia, but proteinuria is largely
unaffected by these measures. Spontaneous tempo-
rary remission of albuminuria has on occasion been
observed in association with measles, and stable re-
mission has been observed in a patient successfully
treated for purulent meningitis which complicated
his illness, but such events are exceedingly rare.
The natural history of this disease is one of per-
sistent albuminuria associated with slowly progres-
sive renal damage leading to hypertension and renal
insufficiency within a period of 3 to 5 years. Death
when it occurs is usually caused by hypertension,
renal failure, or intercurrent infection [7, 24, 42, 45—
48].
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Fig. 7. Comparison of age prevalence of nephrotic syndrome in
American and Nigerian children,
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The serious prognosis associated with this dis-
ease has prompted a search for specific therapy
which has included trials of antimalarial drugs,
prednisolone, and cytotoxic drugs. It is both inter-
esting and instructive to briefly review the sequen-
tial development of therapeutic trials in this dis-
order.
Antimalarial drug therapy. Having confirmed a
definite relationship between P. malariae and the
nephrotic syndrome early in the course of our stud-
ies [5—7], we thought it logical to try the effect of
antimalarial treatment on these patients. Contrary
to earlier reports, we were unable to confirm any
lasting benefits of such treatment. In a controlled
trial in which 44 patients received chloroquin fol-
lowed by weekly pyrimethamine (group A), 45 pa-
tients received no antimalarials (group B), and 24
patients received chloroquin plus primaquine for 14
days, to ensure tissue eradication of P. ,nalariae
(group C), the results assessed 6 months from the
start of therapy showed no difference between the
three groups. Three patients only in groups A and B
and two in group C showed cessation of albumi-
nuria, whereas the remainder in all three groups
showed no improvement or had deteriorated [6].
Predn iso/one. The therapeutic effects of prednis-
olone, which in western countries induces a remis-
sion in most childhood nephrotics, was next investi-
gated either alone or in combination with anti-
malarial treatment [49]. The results of this and
subsequent studies have demonstrated conclusively
that prednisolone is ineffective in inducing a remis-
sion of symptoms in most patients, and its use is
associated with a very high rate of serious compli-
cations, including sudden unexpected death, severe
infections and, most frequent of all, steroid-induced
hypertension with its attendant risks of cerebrovas-
cular accidents and cardiac failure [7, 24, 42, 45, 47—
49]. The risks of prednisolone administration in the
quartan malarial nephrotic syndrome so far out-
weigh the possible benefits to the small minority of
steroid responders, that its general use is con-
traindicated in the management of this condition.
The circumstances in which a trial of prednisolone
is justified are discussed below.
Most children with the nephrotic syndrome in
Europe and America respond well to prednisolone,
and most of these have a highly selective index of
proteinuria: nonresponders tend to have a non-
selective type of proteinuria [37].
Most children with QMN have a poorly selective
type of proteinuria, and a poor response to prednis-
olone is thus to be expected. Of the approximately
20% of the patients with highly selective protein-
uria, less than half show a good response to pre-
dnisolone [42, 45]. This is a lower percentage of re-
sponders than would be expected in similar age
groups with similar selectivity index in Europe and
America, and it indicates that in QMN selectivity
index of proteinuria is less accurate as a means of
identifying prednisolone responders than it is in the
idiopathic nephrotic syndrome. It remains, how-
ever, the simplest means of picking out some ste-
roid responders from the large group of non-
responders. A trial of prednisolone would seem jus-
tified, therefore, in patients who have highly
selective proteinuria, provided that these patients
can be closely observed for early detection of any
untoward effects of prednisolone administration.
Whenever possible, selectivity of proteinuria
should be combined with renal biopsy, which will
permit identification of likely nonresponders (QMN
histology grade II or III) among patients with highly
selective proteinuria, or possible responders (QMN
histology grade I) among patients with poor selec-
tivity [24].
Cytotoxic drugs. The poor response to anti-
malarial drugs and prednisolone in the vast majority
of patients with the QMN syndrome prompted
study of the therapeutic effects of cyclophospha-
mide and azathioprine in this disease. In 1966,
Kibukamusoke reported an impression of striking
benefit from azathioprine therapy in patients ob-
served in East Africa [50]. Subsequent studies in
West Africa have demonstrated conclusively that
azathioprine does not control proteinuria in most
cases and that its use is associated with a signifi-
cantly increased risk of infection and a significant
reduction in the 2-year survival rate when com-
pared with controls [47] (See Fig. 8). On the avail-
able evidence, azathioprine must be regarded as
contraindicated in the treatment of the QMN syn-
drome. The increased mortality observed in pa-
tients treated with azathiaprine is interesting and
could be an example of the postulated system in
which a drug may accelerate renal pathology by
causing more damage to mechanisms concerned
with antigen clearance than it does to the mecha-
nisms causing the renal damage [51, 52].
Cyclophosphamide treatment has sometimes
been associated with complete remission of albu-
minuria, [42, 45, 47], and some reduction in protein-
uria has been observed in many patients given this
drug, but this apparent benefit has not been associ-
ated with improved survival, and the use of cyclo-
phosphamide is attended by serious side effects, no-
chemical findings of the quartan malarial nephrotic
syndrome are similar to those classically described
for the nephrotic syndrome in childhood, but the
renal pathology seen on light, electron, and immu-
nofluorescent microscopy show striking dif-
ferences and distinctive features. The disease tends
to pursue a chronic course and in most patients is
nonresponsive to treatment with antimalarial drugs,
prednisolone, and immunosuppresive drugs. The
overall prognosis is poor, with most patients devel-
oping hypertension and evidence of renal failure
within 3 to 5 years of onset.
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